The global lipid market size is expected to reach USD 23.31 billion by 2030, registering a CAGR of 6.9% over the forecast period. The growth is majorly driven by the rising utilization of products including dietary supplements, functional foods, functional beverages, pharmaceuticals, and more. In addition, increasing demand for lipids in the formulation of vaccines for COVID-19 has further escalated the industry growth. Lipid nanoparticles have high demand due to their wide usage in the pharmaceutical industry as a result of their high efficiency in delivering therapeutics. During COVID-19, it was widely used for transferring mRNA to cells.
Population growth in Asia Pacific has been a key factor for the steady growth of various application industries in the region. Rising consumption of consumer products, healthcare products, foods & beverages, etc. has augmented the demand for chemical ingredients in the region. In addition, the region has the presence of major market players, such as Cargill Inc., BASF SE, and Kerry Group plc, which have been producing lipids in large volumes to fulfill the requirements in the region. The increasing consumption of beverages in China also supports regional growth. Chinese consumers are more inclined toward functional beverages that contain ingredients beneficial to health.
The easy availability of sources, such as plants and animals, has resulted in an increased number of suppliers of raw materials, thereby boosting the region’s growth. However, this results in intense competition in the market, which leads to an inconsistency in prices as well as the availability of raw materials. The pandemic has had a positive impact on market growth. It has also augmented the demand for dietary supplements and medicines. Furthermore, product consumption in the pharmaceuticals industry, particularly for the formulation of COVID-19 vaccines, enhanced its demand during the pandemic.
This product will be delivered within 1-3 business days.
Population growth in Asia Pacific has been a key factor for the steady growth of various application industries in the region. Rising consumption of consumer products, healthcare products, foods & beverages, etc. has augmented the demand for chemical ingredients in the region. In addition, the region has the presence of major market players, such as Cargill Inc., BASF SE, and Kerry Group plc, which have been producing lipids in large volumes to fulfill the requirements in the region. The increasing consumption of beverages in China also supports regional growth. Chinese consumers are more inclined toward functional beverages that contain ingredients beneficial to health.
The easy availability of sources, such as plants and animals, has resulted in an increased number of suppliers of raw materials, thereby boosting the region’s growth. However, this results in intense competition in the market, which leads to an inconsistency in prices as well as the availability of raw materials. The pandemic has had a positive impact on market growth. It has also augmented the demand for dietary supplements and medicines. Furthermore, product consumption in the pharmaceuticals industry, particularly for the formulation of COVID-19 vaccines, enhanced its demand during the pandemic.
Lipid Market Report Highlights
- Triglycerides will be the fastest-growing product segment from 2023 to 2030 on account of the growing product consumption in the production of nutritional foods, dietary supplements, pharmaceuticals, and more
- The food & beverages application segment will register the fastest CAGR from 2023 to 2030 owing to the increasing consumption of food on the account of the rising population
- Asia Pacific will the fastest-growing region from 2023 to 2030due to the increasing consumption of functional foods, dietary supplements, and medicines in countries like China and India
- The presence of government regulations related to the production and consumption of lipids in different countries, owing to the usage of plants & animals for their production, may hinder the industry growth to some extent
- The ongoing European geopolitical conflict between Russia and Ukraine has led to a rise in the prices of oil, energy, natural gas, etc. This situation has resulted in the price hike of raw materials for lipid production
This product will be delivered within 1-3 business days.
Table of Contents
Chapter 1 Methodology and Scope1.1 Market Segmentation & Scope
1.2 Market Definition
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 Internal Database
1.3.3 Secondary Sources
1.3.4 Third Party Perspective
1.3.5 Primary Research
1.3.6 Primary Sources
1.4 Information analysis
1.4.1 Data Analysis Models
1.5 Market formulation & data visualization
1.6 Data validation & publishing
1.7 Research Scope and Assumptions
Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Segmental Outlook
2.3 Competitive Insights
Chapter 3 Market Variables, Trends & Scope
3.1 Market Lineage Outlook
3.1.1 Global Lipid market
3.2 Penetration & Growth Prospect Mapping
3.3 Industry Value Chain Analysis
3.3.1 Raw Material trends
3.3.2 Manufacturing/Technology TRends
3.3.3 Sales channel analysis
3.4 Supply-Demand Analysis
3.4.1 Supply
3.4.2 Demand
3.5 Regulatory Framework
3.6 Price Trend Analysis, 2018 - 2030
3.7 Market Dynamics
3.7.1 Market Driver Impact Analysis
3.7.1.1 Growing global demand for dietary supplements owing to rising health concerns
3.7.2 Increasing usage of lipids in various applications due to their superior functional properties
3.7.3 Market Restraint Impact Analysis
3.7.3.1 Volatile feedstock prices
3.7.4 Industry Challenges
3.8 Impact of COVID-19 On the Industry
3.9 Impact of Eastern European Geopolitical Conflict On the Industry
3.10 Production Cost Analysis
3.11 Opportunities of Nano lipids in pharmaceutical
3.12 Business Environment Analysis
3.12.1 Porter’s Analysis
3.12.2 PESTEL Analysis
Chapter 4 Lipid Market: Product Estimates & Trend Analysis
4.1 Product Movement Analysis & Market Share, 2022 & 2030 (Kilotons) (USD Million)
4.1.1 Ionizable Lipids
4.1.2 Triglycerides
4.1.3 Sphingolipids
4.1.4 Phospholipids
4.1.5 Others (Neutral Lipids, PEGylated Lipids)
Chapter 5 Lipid Market: Phase Estimates & Trend Analysis
5.1 Phase Movement Analysis & Market Share, 2022 & 2030 (Kilotons) (USD Million)
5.1.1 Clinical Phase
5.1.2 Pre-Clinical Phase
5.1.3 Others
Chapter 6 Lipid Market: Application Estimates & Trend Analysis
6.1 Application Movement Analysis & Market Share, 2022 & 2030 (Kilotons) (USD Million)
6.1.1 Pharmaceuticals
6.1.1.1 Vaccines & Drugs
6.1.1.2 Scientific Research
6.1.2 Nutrition & Supplements
6.1.3 Food & Beverages
6.1.4 Others
Chapter 7 Lipid Market: Regional Estimates & Trend Analysis
7.1 Regional Movement Analysis & Market Share, 2022 & 2030 (Kilotons) (USD Million)
7.1.1 North America
7.1.1.1 U.S.
7.1.1.2 Canada
7.1.1.3 Mexico
7.1.2 Europe
7.1.2.1 Germany
7.1.2.2 U.K.
7.1.2.3 France
7.1.2.4 Spain
7.1.2.5 Italy
7.1.2.6 Belgium
7.1.2.7 Russia
7.1.2.8 Turkey
7.1.3 Asia Pacific
7.1.3.1 China
7.1.3.2 India
7.1.3.3 Japan
7.1.3.4 Australia
7.1.3.5 Indonesia
7.1.3.6 Thailand
7.1.3.7 Philippines
7.1.3.8 Malaysia
7.1.3.9 Vietnam
7.1.3.10 South Korea
7.1.4 Central & South America
7.1.4.1 Brazil
7.1.4.2 Argentina
7.1.4.3 Colombia
7.1.5 Middle East & Africa
7.1.5.1 Saudi Arabia
7.1.5.2 South Africa
7.1.5.3 U.A.E.
7.1.5.4 Egypt
7.1.5.5 Nigeria
Chapter 8 Lipid Market - Competitive Landscape
8.1 Recent Developments & Impact Analysis, By Key Market Participants
8.2 Company/Competition Categorization (Key innovators, Market leaders, and Emerging players)
8.3 Vendor Landscape
8.3.1 List of Raw Material Suppliers
8.3.2 List of Manufacturers
8.3.3 List of Key Distributors and Channel Partners
8.3.4 List Of Potential EndUsers
8.4 Key Company Market Positioning Analysis, 2022
8.5 Strategic Framework
Chapter 9 Company Profiles
9.1 Evonik Industries AG
9.1.1 Company Overview
9.1.2 Financial Performance
9.1.3 Product Benchmarking
9.1.4 Strategic Initiatives
9.2 Precision NanoSystems
9.2.1 Company Overview
9.2.2 Financial Performance
9.2.3 Product Benchmarking
9.2.4 Strategic Initiatives
9.3 Merck KGaA
9.3.1 Company Overview
9.3.2 Financial Performance
9.3.3 Product Benchmarking
9.3.4 Strategic Initiatives
9.4 Genevant Sciences
9.4.1 Company Overview
9.4.2 Financial Performance
9.4.3 Product Benchmarking
9.4.4 Strategic Initiatives
9.5 Exelead
9.5.1 Company Overview
9.5.2 Financial Performance
9.5.3 Product Benchmarking
9.5.4 Strategic Initiatives
9.6 Avanti Polar Lipids
9.6.1 Company Overview
9.6.2 Financial Performance
9.6.3 Product Benchmarking
9.6.4 Strategic Initiatives
9.7 Nippon Fine Chemicals Co. Ltd.
9.7.1 Company Overview
9.7.2 Financial Performance
9.7.3 Product Benchmarking
9.8 Lipoid GmbH
9.8.1 Company Overview
9.8.2 Financial Performance
9.8.3 Product Benchmarking
9.8.4 Strategic Initiatives
9.9 Cargill, Incorporated
9.9.1 Company Overview
9.9.2 Financial Performance
9.9.3 Product Benchmarking
9.9.4 Strategic Initiatives
9.10 BASF SE
9.10.1 Company Overview
9.10.2 Financial Performance
9.10.3 Product Benchmarking
9.10.4 Strategic Initiatives
9.11 Archer Daniels Midland Company (ADM)
9.11.1 Company Overview
9.11.2 Financial Performance
9.11.3 Product Benchmarking
9.11.4 Strategic Initiatives
9.12 Koninklijke DSM N.V.
9.12.1 Company Overview
9.12.2 Financial Performance
9.12.3 Product Benchmarking
9.12.4 Strategic initiatives
9.13 Kerry Group plc
9.13.1 Company Overview
9.13.2 Financial Performance
9.13.3 Product Benchmarking
9.13.4 Strategic Initiatives
9.14 Nordic Naturals, Inc.
9.14.1 Company Overview
9.14.2 Financial Performance
9.14.3 Product Benchmarking
9.14.4 Strategic initiatives
9.15 Clover Corporation
9.15.1 Company Overview
9.15.2 Financial Performance
9.15.3 Product Benchmarking
9.16 Croda International plc
9.16.1 Company Overview
9.16.2 Financial Performance
9.16.3 Product Benchmarking
9.16.4 Strategic Initiatives
9.17 Lipoid Kosmetik AG
9.17.1 Company Overview
9.17.2 Financial Performance
9.17.3 Product Benchmarking
9.17.4 Strategic initiatives
9.18 Omega Protein Corporation
9.18.1 Company Overview
9.18.2 Financial Performance
9.18.3 Product Benchmarking
List of Tables
Table 1 Key company/competition categorization
Table 2 List of key Raw Material Suppliers
Table 3 List of Manufacturers
Table 4 List of key distributors and channel partners
Table 5 List of Potential End Users
List of Figures
Fig. 1 Lipid Market Segmentation
Fig. 2 Information Procurement
Fig. 3 Primary Research Pattern
Fig. 4 Data Analysis Models
Fig. 5 Market Formulation And Validation
Fig. 6 Data Validating & Publishing
Fig. 7 Market Snapshot, 2022
Fig. 8 Structural Adhesives Market, Segmental Outlook, 2022 (USD Million)
Fig. 9 Global Lipid Market Volume & Revenue, 2018 - 2030 (Kilotons) (USD Million)
Fig. 10 Global Lipid Market Value Chain Analysis
Fig. 11 Lipid Market Dynamics
Fig. 12 Market Driver Analysis
Fig. 13 Global Dietary Supplements Market, 2018 - 2022 (USD Billion)
Fig. 14 Market Restraint Analysis
Fig. 15 Lipid Market: Porter’s Analysis
Fig. 16 Lipid Market: PESTEL Analysis
Fig. 17 Lipid Market Revenue Share, By Product, 2022 & 2030 (%)
Fig. 18 Lipid Market Revenue Share, By Phase, 2022 & 2030 (%)
Fig. 19 Lipid Market Revenue Share, By Application, 2022 & 2030 (%)
Fig. 20 Lipid Market Revenue Share, By Region, 2022 & 2030 (%)
Fig. 21 Mexico Pharmaceuticals Market Size , 2016 - 2022 (in USD billion)
Fig. 22 Lipid Market: Positioning Analysiss
Fig. 23 Strategic Framework
Companies Mentioned
- Evonik Industries AG
- Precision NanoSystems
- Merck KGaA
- Genevant Sciences
- Exelead
- Avanti Polar Lipids
- Nippon Fine Chemicals Co. Ltd.
- Lipoid GmbH
- Cargill, Incorporated
- BASF SE
- Archer Daniels Midland Company (ADM)
- Koninklijke DSM N.V.
- Kerry Group plc
- Nordic Naturals, Inc.
- Clover Corporation
- Croda International plc
- Lipoid Kosmetik AG
- Omega Protein Corporation
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 150 |
| Published | March 2023 |
| Forecast Period | 2022 - 2030 |
| Estimated Market Value ( USD | $ 13.63 Billion |
| Forecasted Market Value ( USD | $ 23.31 Billion |
| Compound Annual Growth Rate | 6.9% |
| Regions Covered | Global |
| No. of Companies Mentioned | 18 |
